Apr 23, 2026 08:51AM Sutro Biopharma (STRO) PT Raised to $41 at Citizens

Apr 17, 2026 07:19AM Sutro Biopharma (STRO) PT Raised to $35 at Citizens Ahead of AACR Conference

Apr 7, 2026 06:21AM Leerink Partners Starts Sutro Biopharma (STRO) at Outperform

Mar 24, 2026 06:09AM H.C. Wainwright Upgrades Sutro Biopharma (STRO) to Buy

Mar 24, 2026 04:35AM Sutro Biopharma (STRO) Reiterated at Market Outperform by Citizens: 'Shares Undervalued'

Mar 23, 2026 05:32PM Sutro Biopharma Inc. (STRO) files $300M mixed shelf

Feb 10, 2026 07:06AM Sutro Biopharma prices $110 million stock offering at $13.98 per share

Jan 20, 2026 02:43AM Citizens Upgrades Sutro Biopharma (STRO) to Market Outperform

Dec 21, 2025 04:00AM Biotechnology: Here are Piper Sandler's Top Picks and Focus Names for 2026

Nov 17, 2025 04:42AM Sutro Biopharma (STRO) Revealed ADC, STRO-227 at Analyst Event

Nov 6, 2025 06:19PM Sutro Biopharma, Inc. (STRO) Misses Q3 EPS by 27c

Sep 29, 2025 05:05PM Sutro Biopharma cuts workforce by one-third to extend cash runway

Aug 15, 2025 06:01AM Citizens JMP Reiterates Market Perform Rating on Sutro Biopharma (STRO)

Aug 7, 2025 04:40PM Sutro Biopharma, Inc. (STRO) Tops Q2 EPS by 27c

Jul 22, 2025 08:02AM Sutro Biopharma partners with FDA on antibody drug conjugate standards

Jun 16, 2025 03:12AM Piper Sandler Upgrades Sutro Biopharma (STRO) to Overweight

Jun 2, 2025 08:00AM Sutro Biopharma Inc. (STRO) Appoints Greg Chow as CFO

May 9, 2025 04:40PM Sutro Biopharma, Inc. (STRO) Misses Q1 EPS by 6c

Mar 17, 2025 08:18AM H.C. Wainwright Downgrades Sutro Biopharma (STRO) to Neutral

Mar 14, 2025 03:22PM Oppenheimer Downgrades Sutro Biopharma (STRO) to Perform

Mar 14, 2025 03:21PM Sutro Biopharma (STRO) PT Lowered to $8 at Jefferies

Mar 14, 2025 10:15AM Truist Securities Reiterates Buy Rating on Sutro Biopharma (STRO), Removes PT

Mar 14, 2025 06:22AM BofA Securities Double Downgrades Sutro Biopharma (STRO) to Underperform

Mar 14, 2025 04:11AM Wedbush Downgrades Sutro Biopharma (STRO) to Neutral

Mar 14, 2025 03:07AM Citizens JMP Downgrades Sutro Biopharma (STRO) to Market Perform

Mar 13, 2025 04:05PM Sutro Biopharma Inc. (STRO) Announces Strategic Portfolio Review Resulting in the Prioritization of its Next-Generation ADC Pipeline

Feb 3, 2025 04:43AM JMP Securities Biotechnology Overview

Nov 13, 2024 06:06PM Sutro Biopharma, Inc. (STRO) Tops Q3 EPS by 14c

Oct 11, 2024 07:55AM Piper Sandler Reiterates Overweight Rating on Sutro Biopharma (STRO)

Oct 11, 2024 07:01AM BofA Securities Reiterates Buy Rating on Sutro Biopharma (STRO)

Oct 11, 2024 06:36AM H.C. Wainwright Reiterates Buy Rating on Sutro Biopharma (STRO)

Sep 17, 2024 05:54AM Piper Sandler Reiterates Overweight Rating on Sutro Biopharma (STRO)

Sep 16, 2024 09:11AM TD Cowen Reiterates Buy Rating on Sutro Biopharma (STRO)

Aug 22, 2024 08:04AM Sutro Biopharma Inc. (STRO) Announces Initiation of REFRαME-L1 Phase 2 Trial with Luvelta for Patients with Non-Small Cell Lung Cancer

Aug 16, 2024 07:06AM Sutro Biopharma (STRO) PT Lowered to $15 at Truist Securities

Aug 14, 2024 02:21PM TD Cowen Reiterates Buy Rating on Sutro Biopharma (STRO)

Aug 14, 2024 08:25AM Piper Sandler Reiterates Overweight Rating on Sutro Biopharma (STRO)